Levamfetamine

CHEMBL19393 Phase 4 Zugelassen Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

135.2 g/mol

LogP

1.8

Phase

4

This medication is the levorotatory form of amphetamine and acts as a central nervous system stimulant by increasing the release of dopamine and norepinephrine. It has been investigated for use in attention deficit disorders and appetite suppression.

Molekularmasse

135,2100 g/mol

LogP

1,80

TPSA

26,00 Å²

Lipinski-Regel der Fünf

Bestanden

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure

Embed this structure

SMILES

C[C@@H](N)Cc1ccccc1

InChI

InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m1/s1

Molecular Formula

C9H13N

HBD / HBA

1 / 1

Rotierbare Bindungen

2

Schwere Atome

10

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

This medication is the levorotatory form of amphetamine and acts as a central nervous system stimulant by increasing the release of dopamine and norepinephrine. It has been investigated for use in attention deficit disorders and appetite suppression.

Yes, Levamfetamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL19393. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 32893. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Suchen Sie patientenfreundliche Informationen?

Levamfetamine auf PillFYI

Struktur

Schnelldaten

Formel: C9H13N

Externe Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.